Related Experiment Videos
Increased IL-6 gene expression and production in patients with common variable immunodeficiency
F Pandolfi1, R Paganelli, A Oliva
1Department of Allergy and Clinical Immunology, La Sapienza University of Rome, Italy.
Clinical and Experimental Immunology
|May 1, 1993
Summary
Common variable immunodeficiency (CVI) patients show increased interleukin-6 (IL-6) gene expression and production. However, their cells do not enhance immunoglobulin production in response to IL-6.
Area of Science:
- Immunology
- Molecular Biology
Background:
- Common variable immunodeficiency (CVI) is a primary immunodeficiency characterized by low immunoglobulin levels.
- Interleukin-6 (IL-6) is a cytokine with pleiotropic effects, including roles in B-cell differentiation and immunoglobulin production.
Purpose of the Study:
- To investigate IL-6 gene expression and production in peripheral blood mononuclear cells (PBMC) from CVI patients.
- To determine the functional response of CVI cells to IL-6 regarding immunoglobulin secretion.
Main Methods:
- Isolation and in vitro stimulation of PBMC from CVI patients and healthy controls.
- Analysis of IL-6 mRNA expression using hybridization.
- Quantification of IL-6 protein production via ELISA.
- Assessment of immunoglobulin (IgM, IgG) secretion from stimulated PBMC and EBV-transformed cell lines.
Main Results:
- Elevated IL-6 gene expression and protein production were observed in PHA- and PHA/PMA-stimulated PBMC from CVI patients compared to controls.
- IL-6 production did not correlate with lymphocyte subsets or monocyte counts.
- IL-6 enhanced IgM secretion in EBV-transformed cell lines but did not significantly alter IgM or IgG production by activated PBMC from CVI patients.
Conclusions:
- IL-6 gene expression and production are upregulated in CVI.
- Despite increased IL-6 levels, CVI cells exhibit impaired responsiveness to IL-6 for immunoglobulin production.